Development Level

Tbio 9 | 10,625
Tchem 7 | 1,890
Tclin 5 | 602
Tdark 1 | 7,003

IMPC Term

abnormal behavior 1 | 226
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased circulating HDL chol... 1 | 77
decreased circulating choleste... 1 | 85
decreased effector memory CD8-... 1 | 24
decreased exploration in new e... 1 | 9
decreased grip strength 1 | 123
decreased lean body mass 1 | 195
decreased neutrophil cell numb... 1 | 37
decreased total body fat amoun... 1 | 186
hypoactivity 1 | 89
increased bone mineral content 1 | 92
increased circulating chloride... 1 | 43
increased circulating magnesiu... 1 | 10
increased circulating phosphat... 1 | 24
increased lean body mass 1 | 107
tremors 1 | 34

Disease

osteosarcoma 13 | 7,933
ovarian cancer 13 | 8,484
psoriasis 12 | 6,685
glioblastoma 11 | 5,572
Cancer 10 | 2,346
atypical teratoid / rhabdoid tumor 9 | 4,369
intraductal papillary-mucinous neoplasm (IPMN) 9 | 3,289
medulloblastoma, large-cell 9 | 6,234
Alzheimer's disease 7 | 644
astrocytic glioma 7 | 2,241
cutaneous lupus erythematosus 7 | 1,056
pancreatic cancer 7 | 2,300
pilocytic astrocytoma 7 | 3,086
ulcerative colitis 7 | 2,087
Obesity 6 | 616
diabetes mellitus 6 | 1,663
interstitial cystitis 6 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,988
invasive ductal carcinoma 6 | 2,950
pediatric high grade glioma 6 | 2,712
Breast cancer 5 | 3,094
Influenza 5 | 142
Pick disease 5 | 1,893
Polycystic Ovary Syndrome 5 | 332
cystic fibrosis 5 | 1,665
dermatomyositis 5 | 933
juvenile dermatomyositis 5 | 1,189
lung carcinoma 5 | 2,844
oligodendroglioma 5 | 2,849
primitive neuroectodermal tumor 5 | 3,031
Amyotrophic Lateral Sclerosis 4 | 431
Anemia 4 | 252
Atherosclerosis 4 | 275
Autistic Disorder 4 | 320
Carcinoma 4 | 2,147
Cerebrovascular disease 4 | 231
Cocaine-Related Disorders 4 | 88
Diarrhea 4 | 155
Hypertension 4 | 287
Kidney disease 4 | 396
Neurodegenerative disease 4 | 383
Parkinson's disease 4 | 364
Schizophrenia 4 | 501
acute quadriplegic myopathy 4 | 1,157
adult high grade glioma 4 | 2,148
breast carcinoma 4 | 1,614
ductal carcinoma in situ 4 | 1,745
ependymoma 4 | 2,514
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
lung adenocarcinoma 4 | 2,713
lung cancer 4 | 4,466
malignant mesothelioma 4 | 3,162
medulloblastoma 4 | 1,524
pancreatic carcinoma 4 | 567
pituitary cancer 4 | 1,972
posterior fossa group A ependymoma 4 | 1,511
subependymal giant cell astrocytoma 4 | 2,287
tuberculosis 4 | 1,557
Acquired immunodeficiency syndrome 3 | 164
Alcohol dependence 3 | 107
Amphetamine-Related Disorders 3 | 74
Atopic dermatitis 3 | 944
Bipolar Disorder 3 | 266
Brain Ischemia 3 | 87
Brain disease 3 | 83
Constipation 3 | 43
Coronary artery disease 3 | 240
Dementia 3 | 129
Heart disease 3 | 279
Heart failure 3 | 80
Huntington's disease 3 | 72
Hyperglycemia 3 | 120
Hypertensive disease 3 | 193
Inflammation 3 | 109
Lung disease 3 | 132
Lupus erythematosus 3 | 80
Mammary Neoplasms 3 | 410
Multiple Sclerosis 3 | 498
Myocardial Reperfusion Injury 3 | 34
Prostatic Neoplasms 3 | 471
Seizures 3 | 95
Toxic encephalopathy 3 | 131
gastric cancer 3 | 430
glioblastoma multiforme 3 | 347
hepatocellular carcinoma 3 | 532
non-small cell lung carcinoma 3 | 413
Cardiovascular system disease 2 | 194
Collagen disease 2 | 25
Epilepsy 2 | 346
Hyperalgesia 2 | 71
Hypersensitivity reaction type II disease 2 | 235
IGA Glomerulonephritis 2 | 454
Infertility 2 | 163
Inflammatory bowel disease 2 | 142
Movement Disorders 2 | 21
Neuropathy 2 | 210
Peripheral vascular disease 2 | 90
Spontaneous abortion 2 | 108
active Crohn's disease 2 | 918
atypical teratoid/rhabdoid tumor 2 | 1,095

Tissue

Digestive Tract 22 | 18,473
Endocrine System 22 | 18,512
Female tissues 22 | 18,647
Nervous System 22 | 18,561
Urinary Tract 22 | 18,444
Blood and immune system 21 | 17,995
Liver and Pancreas 21 | 18,136
Male tissues 21 | 17,969
Skin and soft tissues 21 | 18,115
Cardiovascular System 20 | 17,958
Respiratory system 20 | 17,484

Target Family

Non-IDG 12 | 11,971
Enzyme 4 | 4,146
GPCR 3 | 406
Transcription Factor 2 | 1,400
Nuclear Receptor 1 | 48

Grant Application

2P51RR000168-47 22 | 22
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Alpha-synuclein SNCA Tchem Non-IDG -3.59982 3997.3 1484
Peptide YY PYY Tbio Non-IDG -3.05547 1229.8 256
Mu-type opioid receptor OPRM1 Tclin GPCR -3.20440 1609.2 372
Trace amine-associated receptor 1 TAAR1 Tclin GPCR -2.43094 290.3 110
Vascular endothelial growth factor A VEGFA Tclin Non-IDG -4.21581 17832.7 1361
Probable ATP-dependent RNA helicase DDX58 DDX58 Tbio Enzyme -2.88678 828.3 369
Angiotensin-converting enzyme 2 ACE2 Tchem Enzyme -2.95438 1065.5 610
B-cell antigen receptor complex-associated protein alpha chain CD79A Tbio Non-IDG -4.42366 27478.2 943
Androgen receptor AR Tclin Nuclear Receptor -3.78107 6683.7 1366